ZimVie has announced that the first patient in the USA has received its newly approved 4.5mm Mobi-C cervical disc device.
Introduced in France in 2004, Mobi-C became the first cervical disc approved for one and two levels by the US Food and Drug Administration (FDA) in 2013. And, as detailed in a ZimVie press release, the smaller, 4.5mm-height Mobi-C implants—available in seven footprints to match patient anatomy—were approved by the US regulator in August of this year.
Even more recently, on 30 October 2023, Gregory Lopez (Midwest Orthopaedics at Rush, Chicago, USA) implanted the first 4.5mm Mobi-C in the USA.
“The 59-year-old patient presented with a significantly collapsed C5–6 disc, and the new lower profile Mobi-C implant allowed me to avoid over-distracting the facet joints,” said Lopez. “The 4.5mm-height Mobi-C makes it possible for me to offer pain relief and motion preservation to more of my patients with cervical disc degeneration.”
“It is an honour to celebrate the first US implantation of the 4.5mm Mobi-C cervical disc,” added Rebecca Whitney, global president of ZimVie Spine. “ZimVie is dedicated to bringing the right products to the market, and it really hits home to know that patients are benefitting from our efforts. We are excited about the recent wins for our market-leading Mobi-C portfolio, including the August FDA approval for the 4.5mm range of implants and the September approval of the Mobi-C Hybrid investigational device exemption (IDE) application, allowing ZimVie to enrol patients in the first ever cervical arthroplasty-fusion study in the USA.”
